Integrated Multi-Omics and Machine Learning Framework Identifies Diagnostic Signatures and Druggable Targets in Breast Cancer
Genes · 30.03.2026 · 17 (4) · 396
DOI: 10.3390/genes17040396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 30.03.2026. Verfasst von Zifu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing, Asia Pacific University of Technology & Innovation, Kuala Lumpur 57000, Wilayah Persekutuan Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Breast Neoplasms, Machine Learning, Biomarkers, Tumor, Checkpoint Kinase 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Breast cancer (BC) is one of the most diagnosed malignancies and a leading cause of cancer-related mortality among women worldwide, thereby posing a substantial threat to women’s health worldwide. However, clinically robust diagnostic biomarkers with high sensitivity and specificity, as well as well-validated molecular targets for targeted therapy, remain limited.
Methods
BC transcriptomic data from seven GEO datasets and the TCGA-BRCA cohort (n = 1231) were integrated for analysis. After batch-effect correction, candidate genes were screened through DEA, WGCNA, and PPI networks analysis. An ensemble machine learning (ML) framework incorporating 127 algorithmic combinations was constructed, and SHAP analysis was applied to identify hub genes. Further analyses included functional enrichment, immune infiltration, miRNA regulatory network analysis, and SMR analysis. The expression patterns were validated using single-cell transcriptome data. Drug repositioning analysis and AI-assisted virtual screening were performed to prioritize compounds with favorable drug-like properties. The predicted binding modes of candidate compounds with CHEK1 were assessed by molecular docking.
Results
Thirty core genes were obtained through differential expression, WGCNA, and PPI screening. Integrated ML (127 algorithms) determined the optimal model (AUC = 0.919), and SHAP identified nine feature genes, among which CHEK1 and KIF23 showed preliminary diagnostic potential across four external cohorts (AUC: 0.625–0.938). Functional enrichment indicated that both are enriched in the cell cycle and p53 pathways, closely associated with BRCA1/ATR; immune infiltration revealed significant correlations with macrophages and CD8+ T cells, with hsa-miR-15a-5p and hsa-miR-607 being common upstream regulatory miRNAs. SMR analysis supported a causal relationship between CHEK1 expression and BC genetic susceptibility (p_SMR < 0.05, p_HEIDI > 0.05); single-cell analysis confirms its heterogeneous expression. AI-assisted virtual screening identified 25 A-grade computational candidate compounds from 171 candidates. Molecular docking suggested that Olaparib and LY294002 can form favorable interactions with the CHEK1 active pocket.
Conclusions
The study identified CHEK1 as a key diagnostic gene for BC through 127 ML algorithms and SMR causal inference. By combining AI-assisted virtual screening and molecular docking, computational candidate compounds targeting CHEK1 were prioritized. These findings represent hypothesis-generating in silico predictions and require experimental validation before any therapeutic conclusions can be drawn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computing, Asia Pacific University of Technology & Innovation, Kuala Lumpur 57000, Wilayah Persekutuan Kuala Lumpur, Malaysia.
- Department of Biological Sciences, Mellon College of Science, Carnegie Mellon University, 4400 Fifth Ave, Pittsburgh, PA 15213, USA.
- Beijing Institute of Remote Sensing Equipment, China Aerospace Science and Industry Corporation Limited, Beijing 100854, China.
Zitieren
APA
Wang, Z., Hou, J., Chen, Y., Li, J., & Vengusamy, S. (2026). Integrated Multi-Omics and Machine Learning Framework Identifies Diagnostic Signatures and Druggable Targets in Breast Cancer. Genes, 17(4), 396. https://doi.org/10.3390/genes17040396
Vancouver
Wang Z, Hou J, Chen Y, Li J, Vengusamy S. Integrated Multi-Omics and Machine Learning Framework Identifies Diagnostic Signatures and Druggable Targets in Breast Cancer. Genes. 2026;17(4):396. doi:10.3390/genes17040396
BibTeX
@article{Wang2026,
author = {Wang, Zifu and Hou, Jinqi and Chen, Yimin and Li, Jundi and Vengusamy, Sivakumar},
title = {Integrated Multi-Omics and Machine Learning Framework Identifies Diagnostic Signatures and Druggable Targets in Breast Cancer},
journal = {Genes},
year = {2026},
volume = {17},
number = {4},
pages = {396},
doi = {10.3390/genes17040396}
}
EUVIMED